This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International
September 23-26, 2024
Hynes Convention CenterBoston, USA

Dr David Vikström
CTO at Xbrane Bioscience


David Vikström is the Chief Technology Officer (CTO) at Xbrane Biopharma. He has a PhD in biochemistry with focus on protein expression in bacteria. He has been working at Xbrane Biopharma since 2010 and has been part of the development of all the current targets in the pipeline including bringing Ximluci (Lucentis biosimilar) to the market.

Agenda Sessions

  • KEYNOTE: Development of High Quality Biosimilars